Chronic Glossitis (Investigational Adjunct)
Highly investigational adjunct for chronic glossitis; no study in glossitis found; treating nutritional, infectious or allergic causes remains primary.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for chronic glossitis. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use here is Tier C investigational.
- What evidence exists?
- Tier C (investigational). No clinical study of leech therapy in glossitis was identified. Evidence-based first-line management is identifying and treating the underlying cause: iron, B12, or folate deficiency; candidiasis with antifungals; geographic tongue (reassurance and topical anesthetics for discomfort); allergic or irritant contact (eliminate triggers); and biopsy of any suspicious lesion to exclude malignancy.
- Main risks
- Bleeding from each bite site for 6 to 10 hours after the leech detaches
- Iron-deficiency anemia from cumulative blood loss across multiple sessions
- Aeromonas hydrophila wound infection from leech gut bacteria (uncommon outside reconstructive surgery, but possible)
- Allergic reaction to leech saliva (rare; ranges from local itching to anaphylaxis)
- Small Y-shaped bite marks or skin colour changes at the bite sites, which usually fade over weeks to months
- Local pain, bruising, swelling, or itching for 1 to 3 days after each session
- Oral placement is NOT standard or appropriate for leech therapy — most reports describe submental or cervical placement
- Risk of bleeding into a richly vascular oral or perioral area
- Who should not consider this
- Patients who have not been worked up for iron, B12, folate deficiency or candidiasis
- Patients with any suspicious lesion that has not been biopsied (oral cancer screening is mandatory)
- Anyone on blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran or heparin (daily aspirin alone is not a contraindication: tell your doctor, who starts with fewer leeches)
- People with hemophilia or any other inherited bleeding disorder
- Patients with anemia
- People with an active infection at the planned application site
- Patients who are pregnant (leech therapy is not done during pregnancy) or breastfeeding (discuss it with your doctor)
- What to ask your clinician
- Have I been tested for B12, folate, iron deficiency, candidiasis, and Sjogren disease?
- Has a suspicious lesion been ruled out by biopsy?
- Where exactly will the leeches be placed (oral placement is generally inappropriate)?
- What is the published evidence base for leeches in glossitis?
- How will success be measured — symptom improvement, appearance, both?
- What is the plan if I do not improve?
- When to seek urgent care
- Bleeding from a bite site that soaks through more than one dressing per hour
- Bleeding that continues more than 24 hours after the leech detached
- Spreading redness, warmth, swelling, pus, or red streaks around any bite site
- Fever over 38.0 C / 100.4 F, chills, or feeling suddenly unwell after a session
- Hives, facial or tongue swelling, throat tightness, or any difficulty breathing
- Sudden weakness, dizziness, fast heart rate, or fainting (possible severe blood loss)
- Tongue swelling causing breathing or swallowing difficulty
- Persistent white or red patch, ulcer, or lump on the tongue lasting more than 3 weeks
- Unexplained tongue pain with hearing loss or facial numbness
What this does NOT mean
- It does not mean leech therapy is FDA-cleared for glossitis — the only FDA clearance is venous congestion in microsurgical reconstruction (K040187, June 2004).
- It does not replace workup for nutritional deficiency, infection, or malignancy.
- It does not address the most common reversible causes (B12, iron, folate, candida).
- It does not have controlled-trial evidence in this indication.
- It does not differentiate benign glossitis from oral cancer — that requires biopsy.
Safety cross-references
Clinical Profile
- Category
- ENT
- ICD-10
- K14.0, K14.1, K14.9
- Safety tier
- High
Evidence Summary
Chronic glossitis (atrophic, geographic, median rhomboid) management per oral medicine guidance includes correcting nutritional deficiencies (B12, folate, iron, riboflavin, niacin), evaluating for candidiasis (especially in immunocompromised patients), removing irritants (sharp dental edges, allergens), and assessing for systemic disease (autoimmune disorders, celiac disease, malabsorption). No clinical study of leech therapy for chronic glossitis was identified in PubMed, Europe PMC, Crossref or Russian-language sources; its use is investigational and any rationale is mechanistic only. Related reports concern other tongue conditions and do not establish benefit in glossitis: small Soviet and Russian series in glossalgia (burning tongue) and oral mucosal paresthesia (Spitsyna 1987, 25 patients per Baskova and Isakhanyan 2004; Iordanishvili 1992, 30 patients), and single case reports of leeches for post-operative or traumatic tongue swelling. Direct intraoral leech application is contraindicated due to mucosal anatomy and aspiration risk. Evidence is grade D.
What the books describe
Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.
- Baskova and Isakhanyan do not describe inflammation of the tongue (glossitis) as a separate disease, and the word “glossitis” does not appear in the book; of the diseases of the tongue, the book describes glossalgia (also called stomalgia) — pain and unusual sensations in the tongue and adjacent areas of the oral mucosa — which the authors list among the indications for hirudotherapy; the book does not compare it with inflammation of the tongue, and what follows retells the data on glossalgia specifically[B1].
- On glossalgia, Baskova and Isakhanyan write that in an observation by Spitsyna (1987) hirudotherapy was prescribed to 25 patients: according to the description, after treatment the burning of the tongue went away, and the swelling and congestion in it disappeared; it is not clear from the text whether there was a comparison group, how long the patients were followed, and whether all of them had this result[B1].
- Next, a comparison of two groups of 10 patients with glossalgia each is described: the control group received conventional treatment, the main group the same plus hirudotherapy; in the main group, on an empty stomach, a tendency toward improved function of the taste receptors was noted, in the control group the trend was positive but statistically nonsignificant; whether pain, burning or inflammation was assessed in these groups is not clear from the text[B1].
- Michalsen et al. do not write about inflammation of the tongue (glossitis).
- In the chapter on indications and contraindications, Baskova and Isakhanyan name, among others, the following cases in which hirudotherapy is contraindicated: hemophilia, hemorrhagic diatheses, anemias, low blood pressure (hypotension), acute vascular insufficiency (shock, collapse, fainting), emaciation, concurrent prescription of anticoagulants (especially with long-term, daily use), concurrent use of alcohol, external use of large doses of mercury preparations together with leeches, individual intolerance, and an extremely negative attitude of the patient toward leeches[B1].
- Michalsen et al. (chapter 8, Flecken and Michalsen) name hemophilia and concurrent use of anticoagulants as an absolute contraindication; in the same chapter, anemia and bone-marrow suppression, HIV infection, a known peptic ulcer or erosive gastritis, severe unstable disease of the internal organs or marked suppression of the immune system, a severe tendency to allergy, and emaciation of any cause are also listed as contraindications[B3].
- Baskova and Isakhanyan consider hirudotherapy relatively contraindicated where leeches could lead to cosmetic defects, advise refraining from it when body temperature is high, and call its use in pregnancy an open question; Michalsen et al. write that treatment involving blood loss is generally contraindicated in pregnancy and that, in their experience, during the acute stage of an infectious disease it can cause weakness and impair wound healing[B1][B3].
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)
Contraindications
- Hemophilia or another bleeding disorder
- Taking anticoagulants (blood thinners such as warfarin or heparin)
- Anemia or suppressed blood formation
- Low blood pressure, shock, collapse or fainting
- Severe wasting (cachexia)
- Intolerance of leeches or a history of severe allergic reactions
- Pregnancy
- Stomach or duodenal ulcer, erosive gastritis
- Acute infectious disease or high fever
- Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
- Drinking alcohol at the time of treatment
- No consent from the patient
- Acute glossitis with airway compromise
- Suspected oral or tongue malignancy
- Untreated B12 or iron deficiency
- Active oral candidiasis or HIV-related oral disease
- Any intraoral or tongue placement
Related Conditions
Chronic Laryngitis (Investigational Cervical Adjunct)
Highly investigational cervical adjunct for chronic laryngitis; no clinical study found; ENT evaluation for underlying causes remains primary.
Chronic Tonsillitis (Investigational Cervical Adjunct)
Highly investigational cervical adjunct for chronic tonsillitis; no clinical study found; tonsillectomy and antibiotics remain primary; cervical leech placement carries carotid-proximity risk.
Cutaneous Lichen Planus (Localized)
Investigational use for localized cutaneous lichen planus refractory to topical corticosteroid; very limited case-report evidence.
Chronic Rhinosinusitis
Investigational use for chronic rhinosinusitis; no clinical study of leech therapy for this condition was identified, and the rationale is mechanistic.
References
- [B1]
Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]
Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.
- [B3]
Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy
ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.
The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.